Stay updated on Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial

Sign up to get notified when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide notice announces an NIH terminology transition, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.4%
    Check dated 2026-10-25T11:44:36.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T12:26:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer shows a newer site revision, changing from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T14:11:54.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A new page revision label v3.7.0 has been added to the study history, replacing the previous revision v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-20T20:13:08.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    On 2026-09-10 the record shows that results have been posted and new sections for Adverse Events, Baseline Characteristics, Contacts/Locations, and Study Status were added (with 2026-08-18 represented as version 53). The prior 2026-05-05 'Results Submitted' entry was removed.
    Difference
    0.4%
    Check dated 2026-09-13T17:35:28.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now shown on the page, replacing Revision: v3.6.5. This indicates a minor platform update that does not affect the study content or user interactions.
    Difference
    0.1%
    Check dated 2026-08-30T11:52:14.000Z thumbnail image

Stay in the know with updates to Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.